These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 20434528)

  • 1. Loss of tau elicits axonal degeneration in a mouse model of Alzheimer's disease.
    Dawson HN; Cantillana V; Jansen M; Wang H; Vitek MP; Wilcock DM; Lynch JR; Laskowitz DT
    Neuroscience; 2010 Aug; 169(1):516-31. PubMed ID: 20434528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of cytoskeletal abnormalities in mice transgenic for wild-type human tau and familial Alzheimer's disease mutants of APP and presenilin-1.
    Boutajangout A; Authelet M; Blanchard V; Touchet N; Tremp G; Pradier L; Brion JP
    Neurobiol Dis; 2004 Feb; 15(1):47-60. PubMed ID: 14751770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylated tau in neuritic plaques of APP(sw)/Tau (vlw) transgenic mice and Alzheimer disease.
    Pérez M; Morán MA; Ferrer I; Avila J; Gómez-Ramos P
    Acta Neuropathol; 2008 Oct; 116(4):409-18. PubMed ID: 18679696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer's disease.
    Sadleir KR; Kandalepas PC; Buggia-Prévot V; Nicholson DA; Thinakaran G; Vassar R
    Acta Neuropathol; 2016 Aug; 132(2):235-256. PubMed ID: 26993139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease.
    Jackson RJ; Rudinskiy N; Herrmann AG; Croft S; Kim JM; Petrova V; Ramos-Rodriguez JJ; Pitstick R; Wegmann S; Garcia-Alloza M; Carlson GA; Hyman BT; Spires-Jones TL
    Eur J Neurosci; 2016 Dec; 44(12):3056-3066. PubMed ID: 27748574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.
    Terwel D; Dewachter I; Van Leuven F
    Neuromolecular Med; 2002; 2(2):151-65. PubMed ID: 12428809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do axonal defects in tau and amyloid precursor protein transgenic animals model axonopathy in Alzheimer's disease?
    Götz J; Ittner LM; Kins S
    J Neurochem; 2006 Aug; 98(4):993-1006. PubMed ID: 16787410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic deletion of Nogo/Rtn4 ameliorates behavioral and neuropathological outcomes in amyloid precursor protein transgenic mice.
    Masliah E; Xie F; Dayan S; Rockenstein E; Mante M; Adame A; Patrick CM; Chan AF; Zheng B
    Neuroscience; 2010 Aug; 169(1):488-94. PubMed ID: 20433905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease and amyloid: culprit or coincidence?
    Skaper SD
    Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.
    Schweig JE; Yao H; Beaulieu-Abdelahad D; Ait-Ghezala G; Mouzon B; Crawford F; Mullan M; Paris D
    Acta Neuropathol Commun; 2017 Sep; 5(1):69. PubMed ID: 28877763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble Conformers of Aβ and Tau Alter Selective Proteins Governing Axonal Transport.
    Sherman MA; LaCroix M; Amar F; Larson ME; Forster C; Aguzzi A; Bennett DA; Ramsden M; Lesné SE
    J Neurosci; 2016 Sep; 36(37):9647-58. PubMed ID: 27629715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axonopathy in an APP/PS1 transgenic mouse model of Alzheimer's disease.
    Wirths O; Weis J; Szczygielski J; Multhaup G; Bayer TA
    Acta Neuropathol; 2006 Apr; 111(4):312-9. PubMed ID: 16520967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accelerated tau pathology with synaptic and neuronal loss in a novel triple transgenic mouse model of Alzheimer's disease.
    Saul A; Sprenger F; Bayer TA; Wirths O
    Neurobiol Aging; 2013 Nov; 34(11):2564-73. PubMed ID: 23747045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
    Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
    Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal accumulation of autophagic vesicles correlates with axonal and synaptic pathology in young Alzheimer's mice hippocampus.
    Sanchez-Varo R; Trujillo-Estrada L; Sanchez-Mejias E; Torres M; Baglietto-Vargas D; Moreno-Gonzalez I; De Castro V; Jimenez S; Ruano D; Vizuete M; Davila JC; Garcia-Verdugo JM; Jimenez AJ; Vitorica J; Gutierrez A
    Acta Neuropathol; 2012 Jan; 123(1):53-70. PubMed ID: 22020633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-dependent axonal degeneration in an Alzheimer mouse model.
    Wirths O; Weis J; Kayed R; Saido TC; Bayer TA
    Neurobiol Aging; 2007 Nov; 28(11):1689-99. PubMed ID: 16963164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice.
    Ribé EM; Pérez M; Puig B; Gich I; Lim F; Cuadrado M; Sesma T; Catena S; Sánchez B; Nieto M; Gómez-Ramos P; Morán MA; Cabodevilla F; Samaranch L; Ortiz L; Pérez A; Ferrer I; Avila J; Gómez-Isla T
    Neurobiol Dis; 2005 Dec; 20(3):814-22. PubMed ID: 16125396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling Alzheimer's disease in transgenic mice: effect of age and of presenilin1 on amyloid biochemistry and pathology in APP/London mice.
    Dewachter I; van Dorpe J; Spittaels K; Tesseur I; Van Den Haute C; Moechars D; Van Leuven F
    Exp Gerontol; 2000 Sep; 35(6-7):831-41. PubMed ID: 11053674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease: insight from transgenic mouse and tissue-culture models.
    Götz J; Schild A; Hoerndli F; Pennanen L
    Int J Dev Neurosci; 2004 Nov; 22(7):453-65. PubMed ID: 15465275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Alzheimer disease: cellular and molecular aspects].
    Octave JN
    Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.